In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Markets recovered in late trades, amid firm European cues, led by rebound in financials and gains in IT shares.
